title: Efficacy of different hemostatic devices for severe liver bleeding: a randomized controlled animal study.
abstract: BACKGROUND
  Correct hemostasis in liver surgery is hard to achieve because of the oozing bleeding. The aim of this study was to compare the potential benefits of a new compress to the 2 commercial hemostatic compresses.
  
  
  METHODS
  Collagen- and cellulose-based hemostatics were investigated. A standardized resection was treated by applying different hemostatics in a randomized order, and bleeding times were measured. Macroscopic evaluation of the liver and tissue sampling for histological investigations were carried out after 21 days.
  
  
  RESULTS
  The bleeding times of bovine collagen (BoCo), protein-coated equine collagen (PECo), and oxidized cellulose (OxCe) were 140 ± 88, 243 ± 140 (P = .005 vs BoCo), and 352 ± 70 s (P < .001 vs BoCo), respectively. Microscopic evaluation of the PECo presented fibrosis and significant inflammation in the implantation zone, whereas BoCo and OxCe caused only fibrosis in the wound area.
  
  
  CONCLUSIONS
  BoCo showed significantly better hemostatic effect than PECo and OxCe.
authors.affiliation: University of Pécs, Pécs, Hungary.
authors.forename: Ildikó
authors.initials: I
authors.lastname: Takács
authors.forename: Jürgen
authors.initials: J
authors.lastname: Wegmann
authors.forename: Szabolcs
authors.initials: S
authors.lastname: Horváth
authors.forename: Andrea
authors.initials: A
authors.lastname: Ferencz
authors.forename: Sándor
authors.initials: S
authors.lastname: Ferencz
authors.forename: Szaniszló
authors.initials: S
authors.lastname: Jávor
authors.forename: Erich
authors.initials: E
authors.lastname: Odermatt
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Rõth
authors.forename: György
authors.initials: G
authors.lastname: Weber
mesh_terms: D000818:Animals; D001684:Biological Dressings; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D002483:Cellulose, Oxidized / Q000627:therapeutic use*; D004338:Drug Combinations; D005340:Fibrinogen / Q000627:therapeutic use*; D006488:Hemostasis, Surgical / Q000295:instrumentation*; D006490:Hemostatics / Q000627:therapeutic use*; D006498:Hepatectomy / Q000009:adverse effects*; D023421:Models, Animal; D011897:Random Allocation; D013552:Swine; D013917:Thrombin / Q000627:therapeutic use*
chemical_list: D002483:Cellulose, Oxidized; D004338:Drug Combinations; D006490:Hemostatics; C518955:TachoSil; C013695:Surgicel; D005340:Fibrinogen; D013917:Thrombin